American HealthCare Capital is pleased to introduce a multi-location, retail, specialty, and compounding pharmacy for sale in the Austin, Texas area. The company has been in business for 7 years. They focus on a wide range of therapies, including hormone replacement, pain management, wound and scar care, sports medicine, dermatology, pediatrics, dentistry, veterinary, erectile dysfunction, palliative care, anti-aging along with nutritional supplements. One of the locations includes both negative and positive ISO class 7 modular clean rooms.
Approximately 91% of their business is walk in and delivery, and 9% of their business is mail order. The company’s revenues were $15.81 Million in 2015 with an adjusted EBITDA of $4.69 Million. In 2016, the company experienced a significant drop in compounding revenue, resulting in year-end total gross revenue of $5.88 Million. For the first two quarters of 2017, the revenue was $4.34 Million with an Adjusted EBITDA $805,000, and their expected run rate is $8.6 Million. The adjusted EBITDA margin is expected to be in the same range or even higher as a result of specific new marketing initiatives.
Each location is fully staffed, and employees are expected to continue working under new ownership. The asking price is $8 Million. The seller is willing to sell a majority percentage of the company on a pro rata basis and participate in a joint venture wherein he provides ongoing, value-added support to the business.
If you would like to learn more, please contact us for a Confidentiality Agreement that will allow us to share more detailed information with you.